Trial Profile
A double-blind, placebo-controlled study of escitalopram in the prevention of depression in patients with acute coronary syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depression
- Focus Therapeutic Use
- Acronyms DECARD
- 01 Jan 2012 Results published in the Journal of Psychosomatic Research.
- 07 Apr 2009 New source identified and integrated (Trials 10: 20 7 Apr 2009).
- 30 Dec 2008 Planned number of patients changed from 266 to 240 as reported by ClinicalTrials.gov.